These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 14059823)

  • 1. THE BASIS FOR THE SIZE DIFFERENCES IN PLAQUES PRODUCED BY VARIANTS OF ENCEPHALOMYOCARDITIS (EMC) VIRUS.
    LIEBHABER H; TAKEMOTO KK
    Virology; 1963 Aug; 20():559-66. PubMed ID: 14059823
    [No Abstract]   [Full Text] [Related]  

  • 2. THE INFLUENCE OF ENCEPHALOMYOCARDITIS (EMC) VIRUS INFECTION ON POTASSIUM TRANSPORT IN L CELLS.
    FARNHAM AE; EPSTEIN W
    Virology; 1963 Nov; 21():436-47. PubMed ID: 14081368
    [No Abstract]   [Full Text] [Related]  

  • 3. STUDIES OF THREE VARIANTS OF MENGO ENCEPHALOMYELITIS VIRUS. 3. EFFECT OF OVERLAY AND POLYANIONS OF PLAQUE SIZE.
    CAMPBELL JB; COLTER JS
    Virology; 1965 Apr; 25():608-19. PubMed ID: 14329134
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of diethylaminoethyl dextran, protamine sulfate and sulfated polysaccharides of agar on the multiplication of Venezuelan equine encephalomyelitis virus in cell cultures].
    Novokhatskiĭ AS; Grigorian SS; Ershov FI
    Vopr Virusol; 1971; 16(3):317-22. PubMed ID: 5167613
    [No Abstract]   [Full Text] [Related]  

  • 5. INTERACTION OF MYXOVIRUSES WITH DEXTRAN SULFATES. II. SPECTRUM OF INHIBITORY ACTIVITY. CHARACTERISTICS OF ANTIVIRAL EFFECTS OF DEXTRAN SULFATES IN TISSUE CULTURE.
    STYK B; RADA B
    Acta Virol; 1964 Jul; 8():312-26. PubMed ID: 14204744
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental studies on the pathogenesis of encephalomyocarditis virus for mice. I. The factor of sex of animal as affecting pathogenicity of inoculum and susceptibility to infection.
    SCHERR GH
    J Bacteriol; 1953 Jul; 66(1):105-11. PubMed ID: 13069474
    [No Abstract]   [Full Text] [Related]  

  • 7. Physical and chemical studies of Mengo virus variants. 3. Absorbance--temperature profiles, sedimentation in dextran sulfate gradients, and total-infectious particle ratios.
    Scraba DG; Hostvedt P; Colter JS
    Can J Biochem; 1970 Apr; 48(4):412-7. PubMed ID: 4315866
    [No Abstract]   [Full Text] [Related]  

  • 8. THE ROLE OF INTERFERON IN TICK-BORNE ENCEPHALITIS VIRUS-INFECTED L CELLS. II. PERSISTENT INFECTION.
    STANCEK D; VILCEK J
    Acta Virol; 1965 Jan; 9():9-17. PubMed ID: 14299366
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral infection of swine with the encephalomyocarditis virus.
    CRAIGHEAD JE; PERALTA PH; MURNANE TG; SHELOKOV A
    J Infect Dis; 1963; 112():205-12. PubMed ID: 14023638
    [No Abstract]   [Full Text] [Related]  

  • 10. DEMONSTRATION OF ENCEPHALOMYOCARDITIS VIRUS ANTIBODY IN HUMAN SERUMS FROM PANAMA.
    CRAIGHEAD JE; PERALTA PH; SHELOKOV A
    Proc Soc Exp Biol Med; 1963 Nov; 114():500-3. PubMed ID: 14104611
    [No Abstract]   [Full Text] [Related]  

  • 11. Distribution of cell receptors and simple sugar inhibitors during encephalomyocarditis virus-cell union.
    Kunin CM
    J Virol; 1967 Apr; 1(2):274-82. PubMed ID: 4318947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. THE ROLE OF INTERFERON IN TICK-BORNE ENCEPHALITIS VIRUS-INFECTED L CELLS. I. ACUTE INFECTION.
    STANCEK D; VILCEK J
    Acta Virol; 1965 Jan; 9():1-8. PubMed ID: 14299351
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of antigenic differences between the diabetogenic and non-diabetogenic variants of encephalomyocarditis virus using monoclonal antibodies.
    Yoon JW; Ko W; Bae YS; Pak CY; Amano K; Eun HM; Kim MK
    J Gen Virol; 1988 May; 69 ( Pt 5)():1085-90. PubMed ID: 2836552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of diabetogenicity attributable to a single amino acid, Ala776, on the polyprotein of encephalomyocarditis virus.
    Bae YS; Yoon JW
    Diabetes; 1993 Mar; 42(3):435-43. PubMed ID: 8381754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathogenesis of experimental infections with encephalomyocarditis (EMC) virus.
    Dickinson L; Griffiths AJ
    Br J Exp Pathol; 1966 Feb; 47(1):35-44. PubMed ID: 4286251
    [No Abstract]   [Full Text] [Related]  

  • 16. The prevalence of encephalomyocarditis virus neutralizing antibodies among various human populations.
    Tesh RB
    Am J Trop Med Hyg; 1978 Jan; 27(1 Pt 1):144-9. PubMed ID: 204206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genomic RNA of diabetogenic encephalomyocarditis virus: characterization and molecular cloning.
    Jordan GW; Cohen SH; Dandekar S; VandenBrink KM
    Virology; 1987 Jul; 159(1):120-5. PubMed ID: 3037773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting effects of polycations on plaquing efficiency of encephalomyocarditis virus variants.
    Craighead JE; Layne CH
    J Virol; 1969 Jan; 3(1):45-51. PubMed ID: 4306302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host-virus relations in encephalomyocarditis (EMC) virus infections. I. Infections of wild rats.
    DAVIES JN; KILHAM L; MASON P
    Am J Trop Med Hyg; 1956 Jul; 5(4):647-54. PubMed ID: 13354886
    [No Abstract]   [Full Text] [Related]  

  • 20. An electron microscopic study of the development of the encephalomyocarditis (EMC) virus propagated in vitro.
    HINZ RW; BARSKI G; BERNHARD W
    Exp Cell Res; 1962 Mar; 26():571-86. PubMed ID: 13907586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.